The Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France
I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I examine the effect of the vintage of prescription drugs (and other variables) on the life expectancy and age-adjusted mortality rates of residents of Germany, using longitudinal, annual, state-level data during the period 2000-2007. The estimates imply that almost half of the 1.7-year increase in German life expectancy during the period 2000-2007 was due to the replacement of older drugs by newer drugs. Next, I examine the effect of the vintage of chemotherapy treatments on age-adjusted cancer mortality rates of residents of France, using longitudinal, annual, cancer-site-level data during the period 2002-2006. The estimates imply that chemotherapy innovation accounted for at least one-sixth of the decline in French cancer mortality rates, and may have accounted for as much as half of the decline.
|Date of creation:||2010|
|Date of revision:|
|Contact details of provider:|| Postal: Poschingerstrasse 5, 81679 Munich|
Phone: +49 (89) 9224-0
Fax: +49 (89) 985369
Web page: http://www.cesifo-group.de
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Mark Bils, 2004. "Measuring the Growth from Better and Better Goods," NBER Working Papers 10606, National Bureau of Economic Research, Inc.
- Christopher J. Ruhm, 2006.
"Macroeconomic Conditions, Health and Mortality,"
in: The Elgar Companion to Health Economics, chapter 1
Edward Elgar Publishing.
- Frank R. Lichtenberg, 2010.
"Has medical innovation reduced cancer mortality?,"
NBER Working Papers
15880, National Bureau of Economic Research, Inc.
- Plutarchos Sakellaris & Daniel J. Wilson, 2001.
"Quantifying embodied technological change,"
Working Paper Series
2001-16, Federal Reserve Bank of San Francisco.
When requesting a correction, please mention this item's handle: RePEc:ces:ceswps:_3095. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Klaus Wohlrabe)
If references are entirely missing, you can add them using this form.